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Noroviruses are understudied because these important enteric pathogens have not been cultured to date. We found
that the norovirus murine norovirus 1 (MNV-1) infects macrophage-like cells in vivo and replicates in cultured primary
dendritic cells and macrophages. MNV-1 growth was inhibited by the interferon-ab receptor and STAT-1, and was
associated with extensive rearrangements of intracellular membranes. An amino acid substitution in the capsid protein
of serially passaged MNV-1 was associated with virulence attenuation in vivo. This is the first report of replication of a
norovirus in cell culture. The capacity of MNV-1 to replicate in a STAT-1-regulated fashion and the unexpected tropism
of a norovirus for cells of the hematopoietic lineage provide important insights into norovirus biology.
Citation: Wobus CE, Karst SM, Thackray LB, Chang KO, Sosnovtsev SV, et al. (2004) Replication of a Norovirus in cell culture reveals a tropism for dendritic cells and
macrophages. PLoS Biol 2(12): e432.
Introduction
Viruses within the genus Norovirus (formerly ‘‘Norwalk-like
viruses’’) of the family Caliciviridae are major agents of acute
gastroenteritis (Green et al. 2001). Norovirus research,
including the development of prevention and control
strategies, has been hampered by the failure to grow these
viruses in cultured cells despite extensive efforts (Duizer et al.
2004). Most noroviruses identified thus far have been
associated with gastrointestinal disease in humans, but
members of the genus have been found in other species as
well (Green et al. 2001; Karst et al. 2003). Our recent discovery
of the first murine norovirus, murine norovirus 1 (MNV-1),
and demonstration of its ability to infect the intestinal tract
of mice following oral inoculation provided an opportunity
to analyze the pathogenesis of this norovirus in mice (Karst et
al. 2003). This previous study demonstrated that the cellular
transcription factor STAT-1 and interferon (IFN) receptors
are critical for resistance to MNV-1 infection in vivo. The
availability of MNV-1 and STAT1-deficient (STAT1/) mice
(Durbin et al. 1996; Meraz et al. 1996) that are highly
susceptible to MNV-1 infection allowed us to revisit efforts to
develop a cell culture system for noroviruses.
Here we show for the first time that MNV-1 grows in
macrophages (M/) and dendritic cells (DCs) and provide the
first tissue culture model for a norovirus. Using this model we
demonstrate that MNV-1 growth in vitro was inhibited by the
IFN-ab receptor and STAT-1. In addition, we isolated the first
three-times plaque-purified strain of MNV-1 (MNV-1.CW1)
and characterized it in vitro and in vivo. Sequencing of serial
passages of MNV-1.CW1 indicated remarkable sequence
stability over time and indicated that an amino acid
substitution in the capsid protein of serially passaged MNV-
1 was associated with a loss of virulence in vivo.
Results/Discussion
MNV-1 Replicates in Murine M/ and DCs
As part of our ongoing investigation into MNV-1 patho-
genesis, STAT1/mice were infected with MNV-1 by the oral
route and tissue sections analyzed by immunohistochemistry
for the presence of MNV-1 protein. MNV-1-specific staining
was observed in spleen and liver 2 d postinfection (Figure 1).
Interestingly, in the liver, Kupffer cells (resident macrophages
of the liver) lining the sinusoids were specifically stained by
MNV-1 immune serum (compare Figure 1A and 1B). In the
spleen, staining was found primarily in the red pulp and the
marginal zone, but also in non-lymphoid cells within the
white pulp (Figure 1C and 1D). This pattern is consistent with
staining of M/ and DCs (Metlay et al. 1990; Leenen et al.
1998). Furthermore, in some cases virus-antigen-positive M/
were detected (Figure 1C).
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Because cells containing viral antigen in infected mice
resembled M/, we examined whether cells of the hemato-
poietic lineage such as M/ and DCs were permissive for
MNV-1 replication in vitro. Bone-marrow-derived M/
(BMM/) and bone-marrow-derived DCs (BMDCs) were
inoculated with a MNV-1 stock derived from the brain of
infected IFNabc receptor/ (IFNabcR/) mice (Karst et al.
2003). Cytopathic effect (CPE) in cell monolayers was visible
within 2 d in STAT1/ BMM/ and BMDCs, but not STAT1/
murine embryonic fibroblasts (MEFs) (Figure 2A). While
BMDCs showed CPE even when STAT-1 was present, wild-
type (wt) BMM/ exhibited less CPE than their STAT1/
counterparts. These data showed that MNV-1 had a marked
tropism for M/ and DCs but not fibroblasts.
We used this information to screen available M/ cell lines
for growth of MNV-1, including the murine lines RAW 264.7
(Raschke et al. 1978) and J774A.1 (Ralph et al. 1975), and the
human/murine hybrid line WBC264-9C (Aksamit 1986). These
cells also showed visible CPE when inoculated with the MNV-
1 stock (Figure 2, data not shown). Plaques were observed
when infected RAW 264.7 monolayers were maintained
under agarose (Figure 2A), allowing us to develop a plaque
assay and quantitate virus titers.
STAT1/BMM/, STAT1/ and wt BMDCs, and RAW 264.7
cells consistently supported the growth of MNV-1, while wt
BMM/ varied in their ability to support virus growth (Figure
2B). BMM/ and BMDCs cells lacking STAT-1 always yielded
higher MNV-1 titers than their wt counterparts. Furthermore,
a low level of virus replication was observed in STAT1/
MEFs, but as reported previously, no virus growth was
observed in wt MEFs (Karst et al. 2003). MNV-1 replication
proceeded rapidly in permissive cells, with newly synthesized
infectious virions first detected in cell lysates 9 to 12 hours
postinfection (h.p.i.). Taken together, these data indicated
that MNV-1 could productively infect M/ and DCs.
Verification of Viral Growth In Vitro
Several approaches were used to verify that the observed
CPE and plaques were caused by MNV-1. We first performed
a clonal selection from the MNV-1 stock (from infected brain
tissue) with three rounds of plaque purification in RAW 264.7
cells to generate the MNV-1.CW1 strain. This strain was
amplified in RAW 264.7 cells, after which virus particles were
concentrated and subjected to purification by isopycnic
centrifugation in CsCl. A distinct band was observed in CsCl
gradients at a density of 1.35 6 0.01 g/cm3, consistent with
that described for noroviruses (Kapikian et al. 1996).
Examination of the material in this fraction by negative
staining electron microscopy showed the presence of virus
particles with calicivirus morphology (Figure 3A). Further-
more, SDS-PAGE analysis of this material revealed a major
protein of approximately 59 kDa, consistent with the
calculated mass of the MNV-1 capsid protein (Figure 3B,C).
Western blot analysis with antibodies generated against
bacterially expressed MNV-1 capsid protein (Figure 3B) and
mass spectrometry (data not shown) confirmed its identity as
the MNV-1 capsid protein. A genomic-sized RNA molecule of
approximately 7.4 kb was detected in nucleic acid isolated
from the purified virions with a probe specific for the MNV-1
genome in Northern blots (data not shown). Finally, a
neutralization assay was performed with the monoclonal
antibody (mAb) A6.2 specific for the MNV-1 capsid protein
(see Materials and Methods). MAb A6.2 specifically bound to
CsCl-purified MNV-1 virions in an immunoassay, while the
isotype-matched mAb 10H2, an anti-reovirus l1c mAb
(Virgin et al. 1991), did not bind (Figure 3D). MAb A6.2, but
not the isotype control antibody 10H2, showed neutralization
activity in a plaque reduction assay for both the virus in the
original brain homogenate (MNV-1), and the three-times
plaque-purified strain MNV-1.CW1 (Figure 3E). Together
these data confirmed that MNV-1 was the infectious agent
Figure 1. MNV-1-Specific Staining In Vivo
Occurs in Cells of the M/ Lineage
Immunohistochemistry was performed
on liver (A and B) and spleen (C and D)
sections from STAT1/ mice 2 d after
oral infection. MNV-1-specific staining
was seen in Kupffer cells of infected
livers when probed with MNV-1 immune
(A) but not preimmune (B) serum. A
selected Kupffer cell lining the sinusoid
is indicated by an arrowhead. MNV-1-
specific staining consistent with M/ was
seen in red pulp (C) and marginal zone
(D) in the spleen. The arrow indicates a
cell with M/ morphology. No staining
was observed in tissues from mice
infected for 1 d, in infected tissues
incubated with preimmune serum, or in
mock-infected tissues incubated with
immune serum. RP, red pulp; WP, white
pulp.
DOI: 10.1371/journal.pbio.0020432.g001
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associated with viral growth observed in the infected cell
cultures.
MNV-1 RNA and Protein Production in Permissive Cells
To compare MNV-1 replication in cells with that of other
caliciviruses, we analyzed viral RNA and protein synthesis in
MNV-1.CW1-infected RAW 264.7 cells. Northern blot analysis
using a probe specific for the positive strand of the MNV-1
genome showed an increase in the accumulation of full-
length (7.4 kb) and subgenomic-length (2.3 kb) MNV-1
genome over time (Figure 3F). Radiolabeled MNV-1-infected
RAW 264.7 cell lysates were analyzed by immunoprecipita-
tion with serum from a MNV-1 infected mouse, and a 59-kDa
protein consistent with the capsid protein was detected as
early as 6 h.p.i. (Figure 3G). Additional proteins accumulated
over time that corresponded in size to expected calicivirus
nonstructural proteins such as the 76-kDa proteinase-
polymerase precursor and an approximately 40-kDa NTPase
protein (Sosnovtsev et al. 2002). These data showed that the
viral RNA and proteins synthesized in infected cells were
consistent with calicivirus replication (Green et al. 2001).
Ultrastructural Examination of MNV-1-Infected RAW 264.7
Cells
Positive-strand RNA viruses (Dales et al. 1965; Mackenzie et
al. 1999; Pedersen et al. 1999), including caliciviruses (Love et
al. 1975; Studdert and O’Shea 1975; Green et al. 2002), are
known to replicate in association with intracellular mem-
branes. Therefore, we examined the ultrastructural morphol-
ogy of MNV-1.CW1-infected RAW 264.7 cells (Figure 4). Over
time, virus-infected cells showed a striking change in overall
morphology and intracellular organization (Figure 4D–4L)
compared to mock-infected cells (Figure 4A–4C). Structures
resembling virus particles were observed within or next to
single- or double-membraned vesicles in the cytoplasm by 12
h.p.i. (Figure 4D). The vesiculated areas increased in size with
time (Figure 4G–4I), and by 24 h.p.i., large numbers of these
vesicles and viral particles occupied most of the cytoplasm,
displacing the nucleus (Figure 4J–4L). In addition, a complete
rearrangement of intracellular membranes with some con-
fronting membranes occurred (Figure 4J), leading to a
rearrangement of the endoplasmic reticulum and loss of an
intact Golgi apparatus (Figure 4E; data not shown). Interest-
ingly, these smooth-membraned vesicles were often sur-
rounded by mitochondria. A small proportion of cells also
showed crystalline arrays of cytoplasmic virus particles (data
not shown). These observations indicate that like other
positive-strand RNA viruses, norovirus RNA replication likely
occurs in association with intracellular membranes.
Characterization of the Plaque-Purified Strain MNV-1.CW1
In Vitro
To determine whether the plaque purification and sequen-
tial amplification of MNV-1 in RAW 264.7 cells had altered its
growth characteristics, different cell types were infected with
passage (P) 3 of MNV-1.CW1. In general, the growth of MNV-
1.CW1 (P3) in wt or STAT1/ M/ and MEFs (Figure 5A) as
well as RAW 264.7 cells (data not shown) was similar to that
observed for the original parental MNV-1 virus stock
(compare Figure 2B and 5A). Virus titers were reproducibly
higher in STAT1/ cells compared to wt cells, and MNV-
1.CW1 (P3) growth was consistently observed in wt BMM/.
Figure 2. MNV-1 from Brain Homogenate Replicates in Cells of the DC and M/ Lineage In Vitro
BMDCs and BMM/, as well as MEFs from wt or STAT1/ mice, and RAW 264.7 cells were infected with a MOI of 0.05.
(A) MNV-1 causes CPE in permissive cells. MNV-1- or mock-infected cells were observed by light microscopy 2 d postinfection. The boxed area is
magnified further to show the border of the plaque.
(B) Infected cell lysates were analyzed in two to four independent experiments by plaque assay at various timepoints postinfection to calculate
standard deviations. For wt BMM/, MNV-1 growth was detected in two out of four experiments.
DOI: 10.1371/journal.pbio.0020432.g002
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These data demonstrated that our plaque purification and
serial passage in RAW 264.7 cells had not changed the
tropism of the virus for primary DCs and M/ and confirmed
the importance of STAT-1 in controlling MNV-1 growth at
the cellular level.
Cellular Factors Controlling MNV-1 Growth In Vitro
Previous studies demonstrated that a lack of STAT-1 or
both IFNabR and IFNcR increase susceptability to MNV-1
infection. Mice lacking individual IFNR, inducible nitric
oxide (iNOS)/, or protein kinase R (PKR)/ are not
susceptible (Karst at al. 2003). Therefore, we determined
whether molecules other than STAT-1 exhibited antiviral
effects at the level of the infected cell. Primary BMM/ from
wt mice or mouse strains deficient in STAT-1, IFNabR,
IFNcR, IFNabcR, iNOS, or PKR were directly compared for
their ability to support virus replication at two different
multiplicities of infection (MOIs) (Figure 5B). Again, BMM/
cells from both wt and STAT1/mice supported MNV-1 virus
replication, with higher titers observed in cells deficient in
STAT-1. Cells obtained from mice lacking both Type I and II
IFNR (IFNabcR/) or Type I IFNR alone (IFNabR/)
supported replication of virus as efficiently as STAT1/ cells.
In addition, wt BMM/ and wt BMDCs secrete IFNa after
MNV-1-infection, as determined by IFNa enzyme-linked
immunosorbent assay (ELISA) (data not shown). This is
consistent with a direct role for IFN signaling in MNV-1
growth but does not rule out the possibility that effects of
STAT-1 and IFNabR occur in vivo prior to explantation of
the bone marrow. Absence of IFNcR, iNOS, or PKR did not
have a statistically significant effect on MNV-1 growth in
BMM/. Together, these data demonstrate that the antiviral
molecules STAT-1 and IFNab are part of a cellular response
that limits norovirus growth.
Figure 3. Characterization of the Triple Plaque-Purified Strain MNV-1.CW1
(A–C) MNV-1.CW1 purified on CsCl density gradients was visualized by (A) negative staining electron microscopy, (C) Coomassie staining, and
(B) Western blot analysis with a polyclonal anti-MNV-1-capsid antibody. Molecular weight markers are indicated in kiloDaltons.
(D) Specific binding of mAb A6.2 to two different concentrations of CsCl-purified MNV-1 particles in an enzyme-linked immunosorbent assay.
(E) Neutralization of MNV-1 from brain homogenate and MNV-1.CW1 by mAb A6.2 but not the isotype control (10H2) mAb in a plaque
neutralization assay. The assay was repeated three times to calculate standard deviations. The limit of detection is indicated by the dashed line.
(F) Timecourse of viral RNA synthesis in RAW 264.7 cells. Northern blot analysis of viral RNA from cells infected with MNV-1.CW1 (MOI of 2.0)
or mock-infected cells. The size of RNA markers in kilobases is shown on the left. The positions of subgenomic- and genomic-length RNA are
indicated on the right. This timecourse is a representative of two independent experiments.
(G) Timecourse of viral protein synthesis in infected RAW 264.7 cells. MNV-1-specific proteins were precipitated from radiolabeled cell lysates of
MNV-1.CW1-infected RAW 264.7 cells (MOI of 2.0) at indicated times after infection. The size of the proteins in kiloDaltons is indicated.
DOI: 10.1371/journal.pbio.0020432.g003
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Characterization of the Plaque-Purified Strain MNV-1.CW1
In Vivo
To address the effects of cell culture adaptation on
virulence, STAT1/ mice were infected orally with MNV-
1.CW1 from three successive passages (P1, P2, and P3) (Figure
6A). Oral administration of MNV-1.CW1 (P1) resulted in
lethal infection, similar to that previously reported for the
parental MNV-1 brain tissue stock (Karst et al. 2003). These
data fulfill a Koch’s postulate with regard to MNV-1 infection
and are consistent with the identification of MNV-1 as the
infectious agent that was passaged in animals in our initial
studies (Karst et al. 2003). In contrast, MNV-1.CW1 (P3) failed
to cause a lethal infection in STAT1/ mice after oral
inoculation, even when administered a dose of 1.5 3 106
plaque-forming units (pfu), 5,000 times greater than the lethal
dose for P1. In addition, immunohistochemical analysis of
sectioned spleen and liver from STAT1/ mice infected
orally with 1.5 3 106 pfu of MNV-1.CW1 (P3) did not reveal
any MNV-1-specific staining, unlike the parental virus (see
Figure 1, data not shown). This striking difference in
virulence and decrease of viral antigen in infected mice,
coupled with an intermediate lethality phenotype of the
MNV-1.CW1 (P2) virus, showed that serial passage of the virus
in cell culture could attenuate MNV-1 virulence in vivo.
Molecular Analysis of Serially Passaged MNV-1.CW1
To examine the molecular basis for this attenuation,
consensus sequence analysis was performed on the RNA
genome of MNV-1 present in the original brain tissue stock
(parental virus), and in viruses from each subsequent cell
Figure 4. Ultrastructural Studies of MNV-1.CW1-Infected RAW 264.7 Cells
Cells were infected with MNV-1.CW1 (P3) (MOI of 2.0) (D–L) or mock-infected (A–C) and processed for electron microscopy 12 (D–F), 18 (G–I),
or 24 (A–C; J–L) h.p.i. MNV-1 particles are indicated by arrows and confronting membranes by arrowheads. VA, vesiculated areas; Nuc, nucleus;
rER, rough endoplasmic reticulum. Scale bars, 200 nm for (A), (D), (G), and (J); 500 nm for (B), (E), (H), and (K); 2 lm for (C), (F), (I), and (L).
DOI: 10.1371/journal.pbio.0020432.g004
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culture passage of MNV-1.CW1 (P1 through P3) (Figure 6B;
Table 1). Three nucleotide changes occurred between the
parental virus and P1, with one of these resulting in an amino
acid substitution (histidine to arginine) at residue 845,
located within the predicted ‘‘3A-like’’ region of the non-
structural polyprotein. In the P2 virus, which retained
virulence but at a reduced level compared to the parental
and P1 viruses, a second nucleotide substitution within the
predicted ‘‘3A-like’’ coding region was observed that caused
an amino acid change (valine to isoleucine) at residue 716.
The partial attenuation of virulence of the P2 virus in vivo is
of interest since the homologous protein in poliovirus, the 3A
protein, alters the amount of cytokines secreted from cells,
with likely effects on viral pathogenesis (Dodd et al. 2001). Of
note, a mixed population of A and G nucleotides was
detected at position 5,941 of the P2 viral genome that could
potentially yield two populations of virus with either amino
acid lysine or glutamic acid at residue 296 of the capsid
protein. In the P3 virus, which was avirulent in mice, the G
nucleotide sequence at position 5,941 emerged as the
predominant sequence. The resulting amino acid substitution
was of interest because of its location within the hyper-
variable P2 domain, which contains the putative receptor-
binding site (Prasad et al. 1994, 1999; White et al. 1996).
However, altered virus binding to permissive cells cannot
explain the attenuated phenotype since the parental virus
and MNV-1.CW1 (P3) replicate to similar levels in BMDCs
and BMM/ in vitro. Similar to our findings, the P2 domain
was also implicated in attenuation of porcine enteric
calicivirus virulence (Guo et al. 2001). This study suggests
that the norovirus capsid protein, especially the hyper-
variable P2 domain, and possibly the 3A-like protein, may
be important sites for the development of virulence-
attenuating mutations.
Conclusion
Detection of MNV-1-positive cells of the M/ and DC
lineage in infected organs of STAT1/mice led to our finding
that MNV-1 grows in these cell types in vitro. This provides
the first tissue culture model for a norovirus. In addition, the
antiviral Type I IFN response with signaling through STAT-1
is crucial for resistance to murine norovirus infection in vivo
and in vitro. Taken together the previous in vivo data (Karst
et al. 2003) and the tropism of this norovirus for cells of the
innate immune system, underscore the importance of the
innate immune response, specifically STAT-1 and Type I
Figure 5. Critical Role for STAT-1 in Limiting MNV-1 Growth In Vitro
(A) MNV-1.CW1 has no defect in viral growth in vitro. Growth curves (MOI of 0.05) were performed two or three times with MNV-1.CW1 (P3) on
indicated cells to calculate standard deviations.
(B) MNV-1 growth in M/ is controlled by STAT-1 and Type I IFNs. BMM/ of the indicated genotype were infected with MNV-1.CW1 (P3) at the
indicated MOI. The experiment was performed twice to calculate standard deviations. The p-values for PKR versus wt infection at MOI 0.05 and
2.0, 0.8867 and 0.1616, respectively, are not significant. Statistical analysis was performed using the paired t-test (GraphPad Prism, version 3.03).
DOI: 10.1371/journal.pbio.0020432.g005
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IFNs, in resistance against norovirus infection. These data
may aid the development of a culture system for human
noroviruses since neither cells of the M//DC lineage nor cells
with defects in the Type I IFN/STAT-1 antiviral pathway have
likely been investigated (Duizer et al. 2004). Furthermore, this
MNV-1 tissue culture model will help elucidate stages of the
viral life cycle and cellular factors essential for norovirus
replication that may provide targets for prevention or
control of an important human disease.
The demonstration of a tropism of MNV-1 for DCs was
unexpected, as a calicivirus tropism for DCs has not been
previously described. However, like MNV-1, other calicivi-
ruses do interact with M/. Viral RNA from rabbit hemor-
rhagic disease virus, a lagovirus, was detected in splenic and
alveolar M/ by in situ hybridization (Kimura et al. 2001). In
addition, feline calicivirus, a vesivirus, showed a small,
transient increase in viral titers in alveolar M/ cultures,
indicative of abortive infections (Langloss et al. 1978). It is
possible that M/ contribute to the spread of the virus
through the host, but it must be noted that M/ supported
MNV-1 growth to a lower extent than DCs unless they lacked
specific immune defense molecules such as STAT-1. This
argues that M/ may be the cell through which STAT1-
dependent innate immunity limits MNV-1 virulence (Karst et
al. 2003).
In contrast to M/, DCs were permissive even when STAT-1
Figure 6. Changes in Virulence of Plaque-
Purified MNV-1 over Multiple Passages Are
Associated with Limited Amino Acid
Changes
(A) Serial passage of MNV-1.CW1 in cell
culture causes attenuation. STAT1/
mice were infected orally with the
indicated virus dose. The number of
mice analyzed is indicated in parenthe-
ses.
(B) Summary of sequence analysis of
MNV-1 over several passages. The nu-
cleotide and amino acid differences
between the indicated viruses are shown
(for detail see Table 1).
DOI: 10.1371/journal.pbio.0020432.g006
Table 1. Sequence Analysis of MNV-1 over Several Passages
Open
Reading
Frame (ORF)
Genomic
Position of
Nucleotide
Position of
Amino Acid
Parental
MNV-1
MNV-1.CW1
(P1)
MNV-1.CW1
(P2)
MNV-1.CW1
(P3)
ORF1 581 192 CAA/CAT (Gln/His) CAT CAT CAT
986 327 GTA/GTG (Val) GTG GTG GTG
1,283 426 CTG/CTA (Leu) CTG CTG CTG
1,556 517 CTA (Leu CTG CTG CTG
2,151 716 GTC (Val) GTC ATC (ValfiIle) ATC
2,539 845 CAT (His) CGT (HisfiArg) CGT CGT
2,816 937 GAC/GAT (Asp) GAT GAT GAT
2,996 997 GTT/GTC (Val) GTC GTC GTC
3,902 1,299 AGT/AGC (Ser) AGT AGT AGT
4,322 1,439 GGC/GGT (Gly) GGC GGC GGC
ORF2 5,262 69 ATT/ATC (Ile) ATC ATC ATC
5,466 137 ACC/ACT (Thr) ACT ACT ACT
5,941 296 AAG (Lys) AAG AAG/GAG (LysfiLys/Glu) GAG (LysfiGlu)
ORF3 6,770 30 AAC (Asn) AAT AAT AAT
Nucleotides are numbered according to consensus sequence of the parental MNV-1 virus genome (in brain tissue stock) as follows: ORF1 (nt 6–5,069), ORF2 (nt 5,056–6,681),
and ORF3 (nt 6,681–7,307), encoding a large polyprotein (viral nonstructural proteins), VP1 (major capsid structural protein), and VP2 (minor capsid structural protein),
respectively. Amino acid residues are numbered according to location in the corresponding ORF. The nucleotide position of interest is underlined and its location in the
codon of the translated ORF is shown. Sequence heterogeneity at a particular residue was determined from the sequence chromatogram, and the data shown represent
direct sequence analysis of PCR-amplified cDNA products. A change in deduced amino acid sequence from the previous passage is indicated in parentheses.
DOI: 10.1371/journal.pbio.0020432.t001
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was present (see Figure 2). DCs are sentinels of the immune
system whose function is to acquire antigens and stimulate
lymphocytes. Intestinal DCs are found in the gut in
specialized lymphoid tissues where they can sample enteric
antigens by extending their dendrites into the gut lumen
(Stagg et al. 2003; Kraehenbuhl and Corbett 2004). We
therefore speculate that DCs in humans and mice provide
noroviruses access to subepithelial regions of the intestine,
thereby contributing to norovirus disease pathogenesis.
Further studies are in progress to address the role of M/
and DCs in the intestine and the physiologic relevance of
these cells for MNV-1 pathogenesis in general.
Material and Methods
Cell cultures and mice. MEFs were generated and cultured as
described previously (Pollock et al. 1997). RAW 264.7 cells were
purchased from ATCC (Manassas, Virginia, United States) and
maintained in DMEM (Cellgro, Mediatech, Herndon, Virginia, United
States) supplemented with 10% low-endotoxin fetal calf serum
(SH30070.03, HyClone, Logan, Utah, United States), 100 U penicil-
lin/ml, 100 lg/ml streptomycin, 10 mM HEPES (N-2-hydroxyethylpi-
perazine-N9-2-ethanesulfonic acid), and 2 mM L-glutamine
(Biosource, Camarillo, California, United States). Bone marrow was
harvested and M/ were cultured as described previously (Heise et al.
1998). To culture DCs, bone marrow cells were resuspended in
RPMI1640 containing 10% low endotoxin fetal calf serum, 2 mM L-
glutamine, 1 mM sodium pyruvate (Biosource), 100 U penicillin/ml,
100 lg/ml streptomycin, 1% nonessential amino acids (Biosource),
and 20 ng/ml recombinant mouse GM-CSF (BD Biosciences, San Jose,
California, United States) and plated at a concentration of 3 3 105
cells/ml in six-well plates in a total volume of 3 ml per well. The
percentage of CD11c-positive DCs was determined by FACS staining
after culturing cells for 7 d at 37 8C and 5% CO2. Approximately 70%
of the cells were CD11c positive.
Wt 129 and STAT1/ mice were purchased from Taconic
(Germantown, New York, United States). IFNabR/, IFNcR/, and
IFNabcR/ (Muller et al. 1994), PKR/ (Yang et al. 1995), and iNOS/
(MacMicking et al. 1995) mice were bred and housed at Washington
University in accordance with all federal and university policies.
Preparation of rabbit anti-MNV-1 serum. Rabbits were immunized
subcutaneously with 140 lg of MNV-1 VLPs in complete Freunds
adjuvant and boosted 4 or 8 wk later with 70 lg of MNV-1 VLPs or 50
lg of UV-inactivated CsCl-purified MNV-1 in incomplete Freunds
adjuvant. Serum was collected two weeks after the last boost, heat
inactivated, and filtered before use.
Immunohistochemistry. Seven-week-old STAT1/ mice were
infected orally with 25ll of brain homogenate containing MNV-1 (6
3 105 pfu) or brain homogenate from uninfected mice. Organs were
collected into 10% buffered formalin and embedded in paraffin for
sectioning by standard methods. Immunohistochemistry was per-
formed as described previously (Weck et al. 1997) using tyramide
signal amplification (NEN Life Science Products, Boston, Massachu-
setts, United States). Slides were blocked in tyramide signal
amplification blocking reagent (NEN Life Science Products) contain-
ing 10% mouse serum (IHC blocking buffer) for 30 min before
adding antibodies. Serum was diluted 1:20,000 (spleen) or 1:100,000
(liver) in IHC blocking buffer, and tissue sections were incubated
overnight at 4 8C. Horseradish peroxidase–conjugated donkey anti-
rabbit secondary antibody (Jackson ImmunoResearch Laboratories,
West Grove, Pennsylvania, United States) was diluted 1:250 in IHC
blocking buffer and applied to tissue sections for 1 h at room
temperature. Biotin-tyramide was added at a dilution of 1:50 in 13
amplification diluent (NEN Life Science Products) for 10 min, slides
were washed, and horseradish peroxidase–conjugated streptavidin
(NEN Life Science Products) was added at a 1:100 dilution in
tyramide signal amplification blocking reagent and incubated for 30
min at room temperature before washing. Antigen was visualized by a
3-min staining with a solution of 3, 39-diaminobenzidine (Vector
Laboratories, Burlingame, California, United States). Slides were
washed and lightly counterstained with hematoxylin, dehydrated, and
covered with Cytoseal XYL (Richard Allan Scientific, Kalamazoo,
Michigan, United States) coverslips. No staining was observed in
infected tissues incubated with preimmune serum or mock-infected
tissues incubated with immune serum.
Infection of cells. Adherent cells were plated in 12-well plates and
allowed to attach for several hours. Infections were carried out at an
MOI of 0.05 or 2.0 for 30 min on ice in a volume of 0.5 ml per well.
DCs were infected in bulk in the same volume. Cells were then washed
twice with 2 ml of ice-cold PBS per well. To allow viral entry, 1 ml of
medium was added to each well, and cells were incubated at 37 8C and
5% CO2 for different time periods. For growth curve samples,
infected cells and media were subjected to two or three cycles of
freezing and thawing before plaque titration.
Generation of mAb A6.2. A MNV-1-seropositive 129 mouse was
injected intraperitoneally with 100 ll of a brain homogenate
containing MNV-1, and the spleen was harvested 3 d later. Hybrid-
oma fusions were performed as described previously (Virgin et al.
1991) with the following modifications. Hybridoma supernatants
were screened for binding to recombinant MNV-1 capsids by ELISA
as described (Karst et al. 2003). Stable hybridomas were characterized
by Western blotting and ELISA after two rounds of subcloning by
limiting dilution. A6.2 was unable to detect MNV-1 capsid protein by
Western blot analysis but specifically bound to recombinant MNV-1
capsids by ELISA. The A6.2 isotype is IgG2a and was determined
using the mouse mAb isotyping kit (Amersham Biosciences, Amer-
sham, United Kingdom) and following manufacturer’s protocol.
MNV-1 plaque assay and plaque neutralization assay. RAW 264.7
cells were seeded into six-well plates at a density of 23106 viable cells
per well. On the following day, 10-fold dilutions of virus inoculum
were prepared in complete DMEM medium and plated in duplicate
wells. Plates were incubated for 1 h at room temperature on a rocking
apparatus before aspirating the inoculum and overlaying the cells
with 2 ml of 37–40 8C 1.5% SeaPlaque agarose in MEM supplemented
with 10% low-endotoxin fet al.calf serum, 1% HEPES, 1% penicillin/
streptomycin, and 2% glutamine (complete MEM) per well. Plates
were incubated at 37 8C and 5% CO2 for 2 d. To visualize plaques,
cells were stained with 2 ml of 56 8C 1.5% SeaKem agarose in
complete MEM containing 1% neutral red per well for 6–8 h.
For plaque neutralization assays, differing concentrations of
purified mAb (A6.2, anti-MNV-1 capsid; isotype control, 10H2, anti-
reovirus l1c) were incubated with equal plaque-forming units of
either MNV-1.CW1 or MNV-1 brain homogenate for 30 min at 37 8C
prior to performing the MNV-1 plaque assay.
Purification of virus particles. RAW 264.7 cells were infected with
MNV-1.CW1 for 2 d at an MOI of 0.05. Cellular debris was removed
from freeze/thaw lysates by low-speed centrifugation for 20 min at
3,000 rpm. Supernatants were layered on top of a 5-ml 30% sucrose
cushion and centrifuged at 4 8C for 2.5 h at 27,000 rpm (90,000 g) in a
SW32 rotor. Cell pellets were then resuspended in PBS andmixed with
CsCl to a final density of 1.335 g/cm3 and centrifuged for at least 18 h
at 35,000 rpm (115,000 g) in a SW55 rotor. A wide lower band (1.35 6
0.01g/cm3) and narrow upper band (1.31 6 0.01g/cm3) were typically
seen in the gradient. Each band was collected by puncturing the side of
the tube with a needle before overnight dialysis against PBS at 4 8C.
Protein analysis. CsCl-purified virions were separated by SDS-
PAGE gel electrophoresis using standard protocols (Sambrook et al.
1989). Proteins were visualized by Coomassie blue staining using the
Simply Blue safe stain (Invitrogen, Carlsbad, California, United States)
according to manufacturer’s instructions. For Western blot analysis,
proteins were transferred to nitrocellulose membrane and incubated
with an anti-MNV-1-capsid rabbit polyclonal antibody, followed by a
peroxidase-labeled secondary antibody, and visualized by ECL
(Amersham Biosciences) according to manufacturer’s instructions.
Immunoprecipitation of radiolabeled infected cell lysates was
performed as described previously (Sosnovtsev et al. 2002) with serum
obtained from a 129 wt mouse infected orally with MNV-1.
Northern blotting. The region of the MNV-1 genome from nt 5,617
to 7,039 was amplified by RT-PCR and cloned into the pGEM-T Easy
(Promega, Madison, Wisconsin, United States) vector between the T7
and SP6 promoters. The resulting plasmid was linearized with Bsu361
and in vitro transcribed with SP6 RNA polymerase (Roche, Indian-
apolis, Indiana, United States) to generate RNA transcript probes for
detection of positive-sense viral RNA, or with T7 polymerase (Roche)
to generate transcripts for detection of negative-sense viral RNA. To
label probes, the transcription reaction was carried out in the
presence of [P32]-UTP according to manufacturer’s recommenda-
tions. Total RNA from virus-infected or mock-infected cells was
isolated using Trizol (Invitrogen) according to the manufacturer’s
recommendations. One microgram of total RNA from MNV-1- or
mock-infected cells was subjected to electrophoresis on a 1%
formaldehyde gel. RNA Millennium Size Markers (Ambion, Austin,
Texas, United States) were used as size markers. Northern blotting
was performed using standard protocols (Sambrook et al. 1989).
Probes were hybridized overnight at 68 8C in 50% formamide
containing 63 SSC, 53 Denhardt’s, 0.5% SDS, and 100 lg/ml ssDNA.
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MNV-1 ELISA. The ELISA was performed as described previously
(Karst et al. 2003) with the following modifications. ELISA plates were
coated overnight at 4 8C with CsCl-purified MNV-1 particles at 0.2 or
1.0 lg/well. Diluted purified anti-MNV-1-capsid (A6.2) and isotype
control (reovirus 10H2) mAbs, as well as the peroxidase-labeled
secondary antibodies, were incubated for 60 min at 37 8C.
Electron microscopy. Negative staining electron microscopy of
CsCl-purified virions was performed as described previously (Karst et
al. 2003). For thin-section electron microscopy, RAW cells were
infected with MNV-1.CW1 at an MOI of 2.0, as described above. At
various times postinfection cells were washed with PBS and fixed with
3% glutaraldehyde diluted in PBS at room temperature for 2 h. Cells
were pelleted and washed with buffer prior to incubation with 1%
osmium tetroxide (in 0.1 M cacodylate buffer) for 40 min at room
temperature. After washing, the cells were incubated overnight at 4
8C in 2% uranyl acetate/80% acetone. The pellets were then
dehydrated with an acetone series and embedded in Epon before
polymerization at 65 8C for 72 h. Ultrathin sections (~60 nm) were cut
with a Micro Star (Huntsville, Texas, United States) diamond knife,
and the sections were stained and contrasted with uranyl acetate and
lead citrate before viewing on a JOEL 1010 electron microscope at 80
kV. Images were captured on a MegaView III side-mounted CCD
camera (Soft Imaging System, Lakewood, Colorado, United States),
and figures were processed using Adobe Photoshop software (Adobe
Systems, San Jose, California, United States).
Consensus sequence analysis of viral RNA. RNA was extracted
from brain tissue or cell culture material with Trizol (Invitrogen) and
reverse transcribed with Superscript II enzyme (Invitrogen). Genome-
specific sequences were PCR-amplified with Elongase enzyme
(Invitrogen) to produce seven overlapping fragments. The DNA
fragments were gel-purifed and sequenced directly with reagents in
the BigDye Terminator version 3.1 Cycle Sequencing Kit (Applied
Biosystems, Foster City, California, United States) on a 3100 DNA
sequencer (Applied Biosystems). Data were analyzed with the
Sequencher software package (Gene Codes Corporation, Ann Arbor,
Michigan, United States). Oligonucleotide primer sequences are
available upon request.
Acknowledgments
This work was supported by National Institutes of Health grant RO1
AI54483 to HWV. CEW was supported by training grant T32-
CA09547 and SMK by training grants T32-CA09547 and T32-
AI07163. We thank W. Beatty for negative staining electron micro-
scopy. LBT was supported by training grant AI007163
Conflicts of interest. The authors have declared that no conflicts of
interest exist.
Author contributions. CEW, SMK, LBT, JMM, KYG, and HWV
conceived and designed the experiments. CEW, SMK, LBT, KOC, SSS,
GB, JMM, and KYG performed the experiments. CEW, SMK, LBT,
KOC, SSS, GB, AK, JMM, KYG, HWV analyzed the data. AK
contributed reagents/materials/analysis tools. CEW, KYG, and HWV
wrote the paper. &
References
Aksamit RR (1986) A human-mouse hybrid cell line that stably expresses
chemotaxis to N-formylmethionyl-leucyl-phenylalanine. Biochem Biophys
Res Commun 138: 1001–1008.
Dales S, Eggers HJ, Tamm I, Palade GE (1965) Electron microscopic study of the
formation of poliovirus. Virol 26: 379–389.
Dodd DA, Giddings TH Jr, Kirkegaard K (2001) Poliovirus 3A protein limits
interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral
infection. J Virol 75: 8158–8165.
Duizer E, Schwab KJ, Neill FH, Atmar RL, Koopmans MP, et al. (2004)
Laboratory efforts to cultivate noroviruses. J Gen Virol 85: 79–87.
Durbin JE, Hackenmiller R, Simon MC, Levy DE (1996) Targeted disruption of
the mouse Stat1 gene results in compromised innate immunity to viral
disease. Cell 84: 443–450.
Green KY, Chanock RM, Kapikian AZ (2001) Human caliciviruses. In: Knipe
DM, Howley PM, editors. Fields virology. Philadelphia: Lippincott Williams
and Wilkins. pp. 841–874..
Green KY, Mory A, Fogg MH, Weisberg A, Belliot G, et al. (2002) Isolation of
enzymatically active replication complexes from feline calicivirus-infected
cells. J Virol 76: 8582–8595.
Guo M, Hayes J, Cho KO, Parwani AV, Lucas LM, et al. (2001) Comparative
pathogenesis of tissue culture-adapted and wild-type Cowden porcine
enteric calicivirus (PEC) in gnotobiotic pigs and induction of diarrhea by
intravenous inoculation of wild-type PEC. J Virol 75: 9239–9251.
Heise MT, Pollock JL, Bromley SK, Barkon ML, Virgin HW (1998) Murine
cytomegalovirus infection suppresses interferon-gamma-mediated MHC
class II expression on macrophages: The role of type I interferon. Virol
241: 331–344.
Kapikian AZ, Estes MK, Chanock RM (1996) Norwalk group of viruses. In: Fields
BN, Knipe DM, Howley PM, editors. Fields virology. Philadelphia:
Lippincott-Raven. pp. 783–810.
Karst SM, Wobus CE, Lay M, Davidson J, Virgin HW (2003) STAT1-dependent
innate immunity to a Norwalk-like virus. Science 299: 1575–1578.
Kimura T, Mitsui I, Okada Y, Furuya T, Ochiai K, et al. (2001) Distribution of
rabbit haemorrhagic disease virus RNA in experimentally infected rabbits. J
Comp Pathol 124: 134–141.
Kraehenbuhl JP, Corbett M (2004) Immunology: Keeping the gut microflora at
bay. Science 303: 1624–1625.
Langloss JM, Hoover EA, Kahn DE, Kniazeef AJ (1978) In vitro interaction of
alveolar macrophages and pneumocytes with feline respiratory viruses.
Infect Immun 20: 836–841.
Leenen PJ, Radosevic K, Voerman JS, Salomon B, van Rooijen N, et al. (1998)
Heterogeneity of mouse spleen dendritic cells: In vivo phagocytic activity,
expression of macrophage markers, and subpopulation turnover. J Immunol
160: 2166–2173.
Love DN, Sabine M (1975) Electron microscopic observation of feline kidney
cells infected with a feline calicivirus. Arch Virol 48: 213–228.
Mackenzie JM, Jones MK, Westaway EG (1999) Markers for trans-Golgi
membranes and the intermediate compartment localize to induced
membranes with distinct replication functions in flavivirus-infected cells. J
Virol 73: 9555–9567.
MacMicking JD, Nathan C, Hom G, Chartrain N, Fletcher DS, et al. (1995)
Altered responses to bacterial infection and endotoxic shock in mice lacking
inducible nitric oxide synthase. Cell 81: 1–10.
Meraz MA, White JM, Sheehan KCF, Bach EA, Rodig SJ, et al. (1996) Targeted
disruption of the Stat 1 gene in mice reveals unexpected physiologic
specificity of the JAK-STAT signalling pathway. Cell 84: 431–442.
Metlay JP, Witmer-Pack MD, Agger R, Crowley MT, Lawless D, et al. (1990) The
distinct leukocyte integrins of mouse spleen dendritic cells as identified with
new hamster monoclonal antibodies. J Exp Med 171: 1753–1771.
Muller U, Steinhoff S, Reis LFL, Hemmi S, Pavlovic J, et al. (1994) Functional
role of type I and type II interferons in antiviral defense. Science 264: 1918–
1921.
Pedersen KW, van der Meer Y., Roos N, Snijder EJ (1999) Open reading frame
1a-encoded subunits of the arterivirus replicase induce endoplasmic
reticulum-derived double-membrane vesicles which carry the viral repli-
cation complex. J Virol 73: 2016–2026.
Pollock JL, Presti RM, Paetzold S, Virgin HW (1997) Latent murine
cytomegalovirus infection in macrophages. Virol 227: 168–179.
Prasad BV, Rothnagel R, Jiang X, Estes MK (1994) Three-dimensional structure
of baculovirus-expressed Norwalk virus capsids. J Virol 68: 5117–5125.
Prasad BV, Hardy ME, Dokland T, Bella J, Rossmann MG, et al. (1999) X-ray
crystallographic structure of the Norwalk virus capsid. Science 286: 287–290.
Ralph P, Prichard J, Cohn M (1975) Reticulum cell sarcoma: An effector cell in
antibody-dependent cell-mediated immunity. J Immunol 114: 898–905.
Raschke WC, Baird S, Ralph P, Nakoinz I (1978) Functional macrophage cell
lines transformed by Abelson leukemia virus. Cell 15: 261–267.
Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning: A laboratory
manual, 2nd ed. Cold Spring Harbor (New York):Cold Spring Harbor
Laboratory Press. 3 v.
Sosnovtsev SV, Garfield M, Green KY (2002) Processing map and essential
cleavage sites of the nonstructural polyprotein encoded by ORF1 of the
feline calicivirus genome. J Virol 76: 7060–7072.
Stagg AJ, Hart AL, Knight SC, Kamm MA (2003) The dendritic cell: Its role in
intestinal inflammation and relationship with gut bacteria. Gut 52: 1522–
1529.
Studdert MJ, O’Shea JD (1975) Ultrastructural studies of the development of
feline calicivirus in a feline embryo cell line. Arch Virol 48: 317–325.
Virgin HW, Mann MA, Fields BN, Tyler KL (1991) Monoclonal antibodies to
reovirus reveal structure/function relationships between capsid proteins
and genetics of susceptibility to antibody action. J Virol 65: 6772–6781.
Weck KE, Dal Canto AJ, Gould JD, O’Guin AK, Roth KA, et al. (1997) Murine
gammaherpesvirus 68 causes severe large vessel arteritis in mice lacking
interferon-gamma responsiveness: A new model for virus induced vascular
disease. Nat Med 3: 1346–1353.
White LJ, Ball JM, Hardy ME, Tanaka TN, Kitamoto N, et al. (1996) Attachment
and entry of recombinant Norwalk virus capsids to cultured human and
animal cell lines. J Virol 70: 6589–6597.
Yang YL, Reis LF, Pavlovic J, Aguzzi A, Schafer R, et al. (1995) Deficient
signaling in mice devoid of double-stranded RNA-dependent protein kinase.
EMBO J 14: 6095–6106.
PLoS Biology | www.plosbiology.org December 2004 | Volume 2 | Issue 12 | e4322084
First In Vitro Replication of a Norovirus
